148 related articles for article (PubMed ID: 30260652)
1. Nanoparticles Targeted against Cryptococcal Pneumonia by Interactions between Chitosan and Its Peptide Ligand.
Tang Y; Wu S; Lin J; Cheng L; Zhou J; Xie J; Huang K; Wang X; Yu Y; Chen Z; Liao G; Li C
Nano Lett; 2018 Oct; 18(10):6207-6213. PubMed ID: 30260652
[TBL] [Abstract][Full Text] [Related]
2. The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation.
Wong CY; Al-Salami H; Dass CR
J Drug Target; 2018 Aug; 26(7):551-562. PubMed ID: 29095650
[TBL] [Abstract][Full Text] [Related]
3. Carboxymethyl chitosan nanoparticles coupled with CD59-specific ligand peptide for targeted delivery of C-phycocyanin to HeLa cells.
Yang P; Li B; Yin QF; Wang YJ
Tumour Biol; 2017 Mar; 39(3):1010428317692267. PubMed ID: 28347253
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of vaccine to dendritic cells by chitosan nanoparticles conjugated with a targeting peptide ligand selected by phage display technique.
Jung SN; Kang SK; Yeo GH; Li HY; Jiang T; Nah JW; Bok JD; Cho CS; Choi YJ
Macromol Biosci; 2015 Mar; 15(3):395-404. PubMed ID: 25393207
[TBL] [Abstract][Full Text] [Related]
5. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
Sheng Y; He H; Zou H
Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
[TBL] [Abstract][Full Text] [Related]
6. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
7. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
[TBL] [Abstract][Full Text] [Related]
8. Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles.
Lalatsa A; Garrett NL; Ferrarelli T; Moger J; Schätzlein AG; Uchegbu IF
Mol Pharm; 2012 Jun; 9(6):1764-74. PubMed ID: 22571402
[TBL] [Abstract][Full Text] [Related]
9. Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.
Chi Y; Zhu S; Wang C; Zhou L; Zhang L; Li Z; Dai Y
J Drug Target; 2016; 24(3):224-32. PubMed ID: 26219518
[TBL] [Abstract][Full Text] [Related]
10. Multistage Continuous Targeting with Quantitatively Controlled Peptides on Chitosan-Lipid Nanoparticles with Multicore-Shell Nanoarchitecture for Enhanced Orally Administrated Anticancer In Vitro and In Vivo.
Su CW; Yen CS; Chiang CS; Hsu CH; Chen SY
Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27634372
[TBL] [Abstract][Full Text] [Related]
11. Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.
Nevagi RJ; Khalil ZG; Hussein WM; Powell J; Batzloff MR; Capon RJ; Good MF; Skwarczynski M; Toth I
Acta Biomater; 2018 Oct; 80():278-287. PubMed ID: 30266637
[TBL] [Abstract][Full Text] [Related]
12. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
Vásquez Marcano RGDJ; Tominaga TT; Khalil NM; Pedroso LS; Mainardes RM
Carbohydr Polym; 2018 Dec; 202():345-354. PubMed ID: 30287009
[TBL] [Abstract][Full Text] [Related]
13. Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles.
Jesus S; Soares E; Costa J; Borchard G; Borges O
Int J Pharm; 2016 May; 504(1-2):59-69. PubMed ID: 26976502
[TBL] [Abstract][Full Text] [Related]
14. Recent advances of chitosan nanoparticles as drug carriers.
Wang JJ; Zeng ZW; Xiao RZ; Xie T; Zhou GL; Zhan XR; Wang SL
Int J Nanomedicine; 2011; 6():765-74. PubMed ID: 21589644
[TBL] [Abstract][Full Text] [Related]
15. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
[TBL] [Abstract][Full Text] [Related]
16. Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery.
Harde H; Agrawal AK; Jain S
Nanomedicine (Lond); 2014 Nov; 9(16):2511-29. PubMed ID: 24593004
[TBL] [Abstract][Full Text] [Related]
17. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
18. Enhanced stability of oral insulin in targeted peptide ligand trimethyl chitosan nanoparticles against trypsin.
Chen J; Liu C; Shan W; Xiao Z; Guo H; Huang Y
J Microencapsul; 2015; 32(7):632-41. PubMed ID: 26401551
[TBL] [Abstract][Full Text] [Related]
19. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
20. Cp1-11 peptide/insulin complex loaded pH-responsive nanoparticles with enhanced oral bioactivity.
Chen X; Ren Y; Feng Y; Xu X; Tan H; Li J
Int J Pharm; 2019 May; 562():23-30. PubMed ID: 30877031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
